Literature DB >> 25939663

Feeder-free and xeno-free culture of human pluripotent stem cells using UCBS matrix.

Yan Ding1, Hua Yang2, Li Yu1, Chang Long Xu2, Yi Zeng3, Ying Qiu2, Dong Sheng Li1.   

Abstract

The ideal medium for human pluripotent stem cells (hPSCs) culture should be feeder-free, xeno-free, and completely defined. The present study aims to establish a new feeder-free and xeno-free system for culturing hPSCs. The system consists of the matrix, which was prepared from human umbilical cord blood serum (UCBS) and used to coat the culture plates, and the xeno-free medium, which was conventional serum-free hES medium supplemented with high concentrations of bFGF and Fibronectin. Compared with matrigel and mouse embryonic fibroblasts (MEFs), the UCBS matrix was proved to be equally suitable for the growth of hPSCs. After a series of experiments with different media and cytokins, the UCBS matrix was found worked the best with the basic medium (BM) supplemented with 20 ng/mL bFGF, 10 ug/mL fibronectin and Y-27632 for culture of hES cells. The hPSCs maintained normal karyotype, high proliferation rate and self-renewal ability after continuous culture more than 10 passages in this feeder-free and xeno-free system. Furthermore, a new human embryonic stem (hES) cell line was derived from discarded day 3 embryos in this newly developed culture system. In conclusion, this feeder-free and xeno-free system could not only be used to the culture hPSCs, but could also be used to derive new hES cell lines.
© 2015 International Federation for Cell Biology.

Entities:  

Keywords:  ROCK inhibitor; human pluripotent stem cells; umbilical cord blood serum

Mesh:

Substances:

Year:  2015        PMID: 25939663     DOI: 10.1002/cbin.10484

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  4 in total

1.  Effect of a feeder layer composed of mouse embryonic and human foreskin fibroblasts on the proliferation of human embryonic stem cells.

Authors:  Hua Yang; Ying Qiu; Xianghui Zeng; Yan Ding; Jianye Zeng; Kehuan Lu; Dongsheng Li
Journal:  Exp Ther Med       Date:  2016-03-30       Impact factor: 2.447

Review 2.  Embryonic Stem Cells in Clinical Trials: Current Overview of Developments and Challenges.

Authors:  Ali Golchin; Alexia Chatziparasidou; Parviz Ranjbarvan; Zahra Niknam; Abdolreza Ardeshirylajimi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Mechanistic Analysis of Physicochemical Cues in Promoting Human Pluripotent Stem Cell Self-Renewal and Metabolism.

Authors:  Nan Hai; Dong Woo Shin; Huanjing Bi; Kaiming Ye; Sha Jin
Journal:  Int J Mol Sci       Date:  2018-11-04       Impact factor: 5.923

Review 4.  Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.

Authors:  Hong Li; Houbo Jiang; Boyang Zhang; Jian Feng
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.